Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
05/1995
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013090A1 Improved interferon polymer conjugates
05/18/1995WO1995013089A1 Compositions and method for stimulating antibody release by b lymphocytes
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013079A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995WO1995013072A1 The use of alfuzosin or terazosin in the treatment of premature ejaculation
05/18/1995WO1995013067A1 Oxazoles for treating cytokine mediated diseases
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995WO1995013062A1 Butyric ester cyto-differentiating agents
05/18/1995WO1995013059A1 Farnesyl derivatives and pharmaceutical compositions containing them
05/18/1995WO1995013054A1 Process for preparing a clodronate preparation
05/18/1995CA2176386A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995CA2176115A1 Compositions and method for stimulating antibody release by b lymphocytes
05/18/1995CA2175994A1 Process for preparing a clodronate preparation
05/18/1995CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
05/18/1995CA2175249A1 Butyric ester cyto-differentiating agents
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995CA2151059A1 Cathepsin-l-specific inhibitor polypeptide
05/17/1995EP0652953A1 Morphogenic protein soluble complex and composition thereof
05/17/1995EP0652948A1 Development of a vector to target gene expression to the epidermis of transgenic animals
05/17/1995EP0652903A1 NEW HUMAN RECOMBINANT $g(g) INTERFERON
05/17/1995EP0652879A1 1-azaadamantane derivatives as 5-ht agonists or antagonists
05/17/1995EP0652877A1 Methanesulphonate
05/17/1995EP0652874A1 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652870A1 Process for preparing chiral (((2-bromoethyl)amino)methyl)-2-nitro-1H-imidazol-1- ethanol and related compounds
05/17/1995EP0652868A1 INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
05/17/1995EP0652867A1 Novel pyridyl- and pyrimidylpiperazine derivatives
05/17/1995EP0652866A1 Azacyclic compounds
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995EP0652768A1 Preparation for activation of natural killer cells (nk-cells), said preparation containing interferon-alpha and histamine, serotonin or substances with corresponding receptor activity
05/17/1995EP0652767A1 Treatment of human lactation failure
05/17/1995EP0652760A1 Therapeutic methods using caesium ions
05/17/1995EP0652748A1 A method of increasing creatine supply depot
05/17/1995EP0553191B1 Pyridine and pyridine n-oxide derivatives of diarylmethyl- piperidines or piperazines, compositions and use thereof
05/17/1995CN1102648A Substituted mono- and bipyridylmethylpyridenes
05/17/1995CN1102645A Phenylglycinamides of heterocyclically substituted phenylacetic acid derivatives
05/17/1995CN1102643A Substituted derivatives of diaminophthalimide
05/17/1995CN1028429C Method for preparing of substd. Thieno (2,3-B)(1,5) benzodiazepine derivatives
05/16/1995US5416209 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes
05/16/1995US5416195 Polypeptide derivatives of granulocyte colony stimulating factor
05/16/1995US5416194 Extracted from horseshoe crab
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416113 Bronchodilators
05/16/1995US5416111 Cyano-containing n-phenyl-amino-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416104 Oxazolidinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416095 Tetrahydro-quinolinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416092 3-azabicyclo[3.2.1]-oct-8-yl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416085 3-oxa-8-azabicyclo[3.2.1]oct-8-yl terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416084 Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/16/1995US5416083 Benzodiazepinyl-terminated non-peptidyl α-succinamidoacyl aminodiols as anti-hypertensive agents
05/16/1995US5416082 Antiserotonine agents
05/16/1995CA1335591C Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
05/16/1995CA1335577C Superoxide dismutase analogs having novel binding properties
05/16/1995CA1335570C Silicon compounds in bone treatment
05/16/1995CA1335568C Cosmetic and skin treatment compositions
05/11/1995WO1995012678A2 Improvements relating to cancer therapy
05/11/1995WO1995012660A2 Recombinant p53 adenovirus methods and compositions
05/11/1995WO1995012612A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/11/1995WO1995012603A1 Matrix metalloprotease inhibitors________________________________
05/11/1995WO1995012592A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995WO1995012591A1 Phenylindole compounds
05/11/1995WO1995012589A1 Process for the preparation of n-4-[(substituted phenyl)alkylthienyl]-, and n-4-[(substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012577A1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
05/11/1995WO1995012575A1 (e)-20(22)-dehydrovitamin d compounds
05/11/1995WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/11/1995WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995WO1995012415A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995WO1995012400A1 Novel enzyme inhibitors, their synthesis, and methods for use
05/11/1995WO1995012398A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
05/11/1995CA2175902A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175837A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
05/11/1995CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995CA2175667A1 Matrix metalloprotease inhibitors________________________________
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2174548A1 Process for the preparation of n-4-¬(substituted phenyl)alkylthienyl|-, and n-4-¬(substituted phenyl)alkylfuryl|but-3-yn-2-yl|-n-hydroxyurea compounds
05/11/1995CA2174234A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors
05/11/1995CA2172377A1 Novel 4-piperidinyl substituted lactames as neurokinin 2-receptor antagonists for the treatment of asthma
05/11/1995CA2170766A1 Substituted di- and tripeptide inhibitors of protein:farnesyl transferase
05/11/1995CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/10/1995EP0652285A2 Lactic acid bacteria and fermented milk product
05/10/1995EP0652231A1 NON-TOXIC RIBOSOME INACTIVATING PROTEINS (RIPs) WITH TWO CHAINS, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
05/10/1995EP0652228A1 Urethanes and ureas that induce cytokine production
05/10/1995EP0652208A1 Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity
05/10/1995EP0652002A1 Methods for inhibiting cartilage degradation
05/10/1995EP0652000A1 Methods for inhibiting angiogenisis and angiogenic diseases
05/10/1995EP0651998A1 Methods for inhibiting bone loss
05/10/1995EP0651802A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof
05/10/1995EP0651801A1 Polypeptides having serotoninergique activity (5ht5a), nucleic acids coding for these polypeptides and uses thereof
05/10/1995EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
05/10/1995EP0651759A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
1 ... 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 ... 1564